查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1606600

梭菌診斷市場：按診斷測試、最終用戶分類 - 2025-2030 年全球預測

Clostridium Diagnostics Market by Diagnostic Test (Blood Test, Colonoscopy/Sigmoidoscopy, Enzyme Immunoassays), End User (Diagnostic Centers, Hospitals, Specialty Clinics) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023 年，梭菌診斷市場價值為 14.3 億美元，預計到 2024 年將達到 15.1 億美元，複合年成長率為 6.33%，到 2030 年將達到 22 億美元。

梭菌診斷的範圍包括梭狀菌感染的檢測、識別和管理，尤其是困難梭狀芽孢桿菌，事實上，由於其與抗生素相關的腹瀉和結腸炎的相關性，它在醫療保健環境中是一個重要的問題。這個診斷領域至關重要，因為梭狀菌感染可能會造成嚴重後果，需要及時、準確的診斷，以限制感染的傳播並最佳化治療途徑。應用在醫院、學術研究中心和診斷實驗室中非常突出，支持有效的感染控制和病患管理策略。最終用途範圍從醫療保健到開發新診斷技術的生物技術公司。

主要市場統計
基準年[2023] 14.3億美元
預測年份 [2024] 15.1億美元
預測年份 [2030] 22億美元
複合年成長率（%） 6.33%

市場成長受到梭狀菌感染日益普及、醫療保健相關感染 (HAI) 意識不斷提高以及對精確診斷測試的需求的影響。快速診斷測試（包括基於 PCR 的測試和免疫測量）的出現進一步刺激了市場。一個值得注意的機會在於人工智慧和機器學習的整合，以提高診斷的早期檢測和預測準確性，從而推動創新。遠端醫療的角色不斷擴大也可能增強遠距離診斷能力，並為市場擴張提供前沿。然而，與某些診斷測試相關的高成本以及需要熟練的專業人員解釋複雜結果的限制。挑戰包括核准新診斷的監管障礙以及開發高效且具有成本效益的診斷解決方案的競賽。

創新領域包括次世代定序技術、多重檢測以及可快速提供結果的就地檢驗設備的開發。此外，了解梭菌抗藥性機制的研究和分析診斷資料的生物資訊解決方案也可能會推動重大進展。梭狀芽孢桿菌診斷市場的性質是動態的，受到快速的技術進步和不斷發展的優先考慮感染控制的醫療保健政策的影響。為了利用市場機會，相關人員應專注於合作研究，投資於簡化和增強診斷工作流程的技術，並倡導政策支持以降低治療成本。

市場動態：快速發展的梭菌診斷市場的關鍵市場洞察

供需的動態交互作用正在改變梭菌診斷市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 梭菌相關疾病的高盛行率
    • 世界老年人口的增加
  • 市場限制因素
    • 診斷測試出現假陽性或假陰性的潛在風險
  • 市場機會
    • 診斷設備中的人工智慧整合和自動化
    • 採用可攜式POCT 產品
  • 市場挑戰
    • 發展中地區診斷中心的知名度和可用性有限

波特五力：開拓梭狀芽孢桿菌診斷市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對梭菌診斷市場的影響

外部宏觀環境因素在塑造梭菌診斷市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解梭菌診斷市場的競爭狀況

對梭菌診斷市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣梭菌診斷市場供應商的績效評估

FPNV 定位矩陣是評估梭菌診斷市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

制定梭菌診斷市場成功之路的策略分析與建議

對於旨在加強其在全球市場的影響力的公司來說，對梭狀芽孢桿菌診斷市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 梭菌相關疾病的高盛行率
      • 全球人口老化仍在持續
    • 抑制因素
      • 診斷測試出現假陽性或假陰性結果的潛在風險
    • 機會
      • 診斷設備中的人工智慧整合和自動化
      • 可攜式POCT產品介紹
    • 任務
      • 發展中地區診斷中心的認知度和可用性有限
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 梭菌診斷藥品市場診斷試驗

  • 驗血
  • 大腸鏡檢查/乙狀結腸鏡檢查
  • 酵素免疫分析法
  • 核擴增試驗（NAAT）
  • 反應（RT-PCR）
  • 即時聚合酵素鏈
  • 糞便檢驗

第 7 章 梭狀芽孢桿菌診斷市場：依最終使用者分類

  • 診斷中心
  • 醫院
  • 專科診所

第8章北美和南美的梭菌診斷市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區梭菌診斷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲梭狀芽孢桿菌診斷市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • altona Diagnostics GmbH
  • Beckman Coulter, Inc.
  • Becton, Dickinson & Company
  • bioMerieux SA
  • Cepheid
  • DiaSorin SpA
  • F. Hoffmann-La Roche AG
  • Ferring BV
  • Fujirebio Holdings Inc.
  • Hologic, Inc.
  • Luminex Corporation
  • Merck & Co., Inc.
  • Meridian Bioscience, Inc.
  • Molbio Diagnostics Pvt. Ltd.
  • Olympus Corporation
  • Pfizer Inc.
  • QIAGEN NV
  • Quidel Corporation
  • R-Biopharm AG
  • Summit Therapeutics, Inc.
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • Trinity Biotech Plc
  • ZeptoMetrix, LLC
Product Code: MRR-DD0700E81E26

The Clostridium Diagnostics Market was valued at USD 1.43 billion in 2023, expected to reach USD 1.51 billion in 2024, and is projected to grow at a CAGR of 6.33%, to USD 2.20 billion by 2030.

The scope of Clostridium Diagnostics encompasses the detection, identification, and management of Clostridium infections, most notably Clostridium difficile, which is a significant concern in healthcare settings due to its correlation with antibiotic-related diarrhea and colitis. This diagnostic field is crucial as Clostridium infections can cause severe outcomes, necessitating timely and accurate diagnosis to mitigate the spread of infection and optimize treatment routes. Applications are prominent in hospitals, academic research centers, and diagnostic laboratories, where they support effective infection control and patient management strategies. The end-use scope extends from healthcare providers to biotechnology firms developing novel diagnostic technologies.

KEY MARKET STATISTICS
Base Year [2023] USD 1.43 billion
Estimated Year [2024] USD 1.51 billion
Forecast Year [2030] USD 2.20 billion
CAGR (%) 6.33%

Market growth is influenced by the increasing prevalence of Clostridium infections, heightened awareness about healthcare-associated infections (HAI), and the demand for precise diagnostic testing. The advent of rapid diagnostic tests, including PCR-based and immunoassays, further fuels the market. A notable opportunity lies in the integration of artificial intelligence and machine learning to enhance early detection and prediction accuracy in diagnostics, driving innovation. The expanding role of telemedicine could also augment remote diagnostic capabilities, presenting a frontier for market expansion. However, limitations revolve around high costs associated with certain diagnostic tests and the need for skilled professionals to interpret complex results. Challenges include the regulatory hurdles for new diagnostic approvals and competition in developing efficient, cost-effective diagnostic solutions.

Innovation areas include the development of next-generation sequencing technologies, multiplex assays, and point-of-care testing devices that deliver results promptly. Additionally, research concentrated on understanding Clostridium resistance mechanisms and bioinformatics solutions to analyze diagnostic data can spur significant advancements. The nature of the Clostridium Diagnostics market is dynamic, shaped by rapid technological advancements and evolving healthcare policies prioritizing infection control. To capitalize on market opportunities, stakeholders should focus on collaborative research efforts and invest in technologies that streamline and enhance diagnostic workflows while advocating for policy-driven support to reduce treatment costs.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Clostridium Diagnostics Market

The Clostridium Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • High prevalence of clostridium-related disease
    • Growing geriatric population globally
  • Market Restraints
    • Potential risk of false positive or false negative results through diagnostic test
  • Market Opportunities
    • AI integration and automation in diagnostic devices
    • Adoption of portable POCT products
  • Market Challenges
    • Limited awarness and availability of diagnostic centers in developing areas

Porter's Five Forces: A Strategic Tool for Navigating the Clostridium Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Clostridium Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Clostridium Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Clostridium Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Clostridium Diagnostics Market

A detailed market share analysis in the Clostridium Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Clostridium Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Clostridium Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Clostridium Diagnostics Market

A strategic analysis of the Clostridium Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Clostridium Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, altona Diagnostics GmbH, Beckman Coulter, Inc., Becton, Dickinson & Company, bioMerieux SA, Cepheid, DiaSorin SpA, F. Hoffmann-La Roche AG, Ferring BV, Fujirebio Holdings Inc., Hologic, Inc., Luminex Corporation, Merck & Co., Inc., Meridian Bioscience, Inc., Molbio Diagnostics Pvt. Ltd., Olympus Corporation, Pfizer Inc., QIAGEN NV, Quidel Corporation, R-Biopharm AG, Summit Therapeutics, Inc., Sysmex Corporation, Thermo Fisher Scientific, Inc., Trinity Biotech Plc, and ZeptoMetrix, LLC.

Market Segmentation & Coverage

This research report categorizes the Clostridium Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Diagnostic Test, market is studied across Blood Test, Colonoscopy/Sigmoidoscopy, Enzyme Immunoassays, Nucleic Amplification Tests (NAAT), Reaction (RT-PCR), Real-Time Polymerase Chain, and Stool Test.
  • Based on End User, market is studied across Diagnostic Centers, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High prevalence of clostridium-related disease
      • 5.1.1.2. Growing geriatric population globally
    • 5.1.2. Restraints
      • 5.1.2.1. Potential risk of false positive or false negative results through diagnostic test
    • 5.1.3. Opportunities
      • 5.1.3.1. AI integration and automation in diagnostic devices
      • 5.1.3.2. Adoption of portable POCT products
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awarness and availability of diagnostic centers in developing areas
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Clostridium Diagnostics Market, by Diagnostic Test

  • 6.1. Introduction
  • 6.2. Blood Test
  • 6.3. Colonoscopy/Sigmoidoscopy
  • 6.4. Enzyme Immunoassays
  • 6.5. Nucleic Amplification Tests (NAAT)
  • 6.6. Reaction (RT-PCR)
  • 6.7. Real-Time Polymerase Chain
  • 6.8. Stool Test

7. Clostridium Diagnostics Market, by End User

  • 7.1. Introduction
  • 7.2. Diagnostic Centers
  • 7.3. Hospitals
  • 7.4. Specialty Clinics

8. Americas Clostridium Diagnostics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Clostridium Diagnostics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Clostridium Diagnostics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. altona Diagnostics GmbH
  • 3. Beckman Coulter, Inc.
  • 4. Becton, Dickinson & Company
  • 5. bioMerieux SA
  • 6. Cepheid
  • 7. DiaSorin SpA
  • 8. F. Hoffmann-La Roche AG
  • 9. Ferring BV
  • 10. Fujirebio Holdings Inc.
  • 11. Hologic, Inc.
  • 12. Luminex Corporation
  • 13. Merck & Co., Inc.
  • 14. Meridian Bioscience, Inc.
  • 15. Molbio Diagnostics Pvt. Ltd.
  • 16. Olympus Corporation
  • 17. Pfizer Inc.
  • 18. QIAGEN NV
  • 19. Quidel Corporation
  • 20. R-Biopharm AG
  • 21. Summit Therapeutics, Inc.
  • 22. Sysmex Corporation
  • 23. Thermo Fisher Scientific, Inc.
  • 24. Trinity Biotech Plc
  • 25. ZeptoMetrix, LLC

LIST OF FIGURES

  • FIGURE 1. CLOSTRIDIUM DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. CLOSTRIDIUM DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. CLOSTRIDIUM DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLOSTRIDIUM DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CLOSTRIDIUM DIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COLONOSCOPY/SIGMOIDOSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY ENZYME IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY NUCLEIC AMPLIFICATION TESTS (NAAT), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY REACTION (RT-PCR), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY REAL-TIME POLYMERASE CHAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY STOOL TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 37. AUSTRALIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 39. CHINA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 41. INDIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 43. INDONESIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 45. JAPAN CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 47. MALAYSIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 49. PHILIPPINES CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 51. SINGAPORE CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 53. SOUTH KOREA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 55. TAIWAN CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 57. THAILAND CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 59. VIETNAM CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 64. DENMARK CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 66. EGYPT CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 68. FINLAND CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 70. FRANCE CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 72. GERMANY CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 74. ISRAEL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 76. ITALY CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 78. NETHERLANDS CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 80. NIGERIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 82. NORWAY CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 84. POLAND CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 86. QATAR CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 88. RUSSIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 90. SAUDI ARABIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH AFRICA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 94. SPAIN CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 96. SWEDEN CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 98. SWITZERLAND CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 100. TURKEY CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED ARAB EMIRATES CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED KINGDOM CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. CLOSTRIDIUM DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 106. CLOSTRIDIUM DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023